Expert Exchange: SpaceX plummets back down to earth after explosive IPO debut
SpaceX has revisited its $135 listing price after an explosive IPO as investors reassess lofty valuations ahead of its first earnings report.
Market Cap $19.39M
!
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Last update - 16.07pm 31/07/2026 (20 minute delay)
?
| Day | ||||||||
|---|---|---|---|---|---|---|---|---|
| Open | 1.0¢ | Day High | 1.2¢ | Day Low | 1.0¢ | |||
| Daily Volume | 2294043 | |||||||
| Bids | Sellers | |||||
|---|---|---|---|---|---|---|
| Number | Price | Volume | Number | Price | Volume | |
| 0 | 1.1¢ | 91 | 0 | 1.2¢ | 468646 | |
Directors & Senior Management
| Prof. Bruce Thompson | Member of Medical & Scientific Advisory Board |
| Dr. Gerard J. Criner | Member of Medical Advisory Board |
| Mr. Jonathan Adams | Non-Executive Director |
| Dr. Jonathan Hovda | Member of Medical Advisory Board |
| Mr. Marjan Mikel | CEO, MD & Executive Director |
| Mr. Nicholas Smedley | Executive Chairman |
| Prof. Noam Gavriely | Medical & Scientific Advisor |
| Mr. Peter Hildebrandt | Chief Operations Officer |
| Dr. Samaneh Sarraf Shirazi | Chief Research Officer |
| Mr. Simon Godfrey | Medical & Scientific Advisor |
| Dr. Stephen Selinger | Member of Medical Advisory Board |
| Mr. Tony Di Pietro | Company Secretary |
| Dr. William S. Krimsky | Chair of Medical Advisory Board |
| Mr. William Sigsbee | Head of US Operations & Chief Commercial Officer for the US market |
Data source: ADVFN
